Annual Operating Profit
-$101.68 M
-$8.57 M-9.20%
31 December 2023
Summary:
CymaBay Therapeutics annual operaing income is currently -$101.68 million, with the most recent change of -$8.57 million (-9.20%) on 31 December 2023. During the last 3 years, it has fallen by -$14.10 million (-16.10%).CBAY Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$42.50 M
-$10.29 M-31.95%
31 December 2023
Summary:
CymaBay Therapeutics quarterly operating income is currently -$42.50 million, with the most recent change of -$10.29 million (-31.95%) on 31 December 2023.CBAY Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$101.68 M
-$19.02 M-23.01%
31 December 2023
Summary:
CymaBay Therapeutics TTM operating income is currently -$101.68 million, with the most recent change of -$19.02 million (-23.01%) on 31 December 2023.CBAY TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBAY Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -16.1% | -73.4% | -16.1% |
| 5 y5 years | +1.4% | -66.9% | +1.4% |
CBAY Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +982.2% | >+9999.0% | +4110.3% |
CymaBay Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$101.68 M(+9.2%) | -$42.50 M(+32.0%) | -$101.68 M(+23.0%) |
| Sept 2023 | - | -$32.21 M(>+9900.0%) | -$82.66 M(+15.1%) |
| June 2023 | - | -$99.00 K(-99.6%) | -$71.81 M(-24.8%) |
| Mar 2023 | - | -$26.88 M(+14.5%) | -$95.48 M(+2.5%) |
| Dec 2022 | -$93.11 M(+6.3%) | -$23.48 M(+9.9%) | -$93.11 M(-1.1%) |
| Sept 2022 | - | -$21.36 M(-10.1%) | -$94.14 M(-0.9%) |
| June 2022 | - | -$23.77 M(-3.0%) | -$94.97 M(+0.5%) |
| Mar 2022 | - | -$24.50 M(-0.0%) | -$94.47 M(+7.9%) |
| Dec 2021 | -$87.58 M(+66.5%) | -$24.51 M(+10.5%) | -$87.58 M(+10.9%) |
| Sept 2021 | - | -$22.19 M(-4.6%) | -$78.95 M(+15.4%) |
| June 2021 | - | -$23.27 M(+32.1%) | -$68.41 M(+21.5%) |
| Mar 2021 | - | -$17.62 M(+11.0%) | -$56.29 M(+7.0%) |
| Dec 2020 | -$52.60 M(-49.0%) | -$15.87 M(+36.2%) | -$52.60 M(-15.4%) |
| Sept 2020 | - | -$11.65 M(+4.5%) | -$62.20 M(-20.5%) |
| June 2020 | - | -$11.15 M(-19.9%) | -$78.25 M(-15.6%) |
| Mar 2020 | - | -$13.93 M(-45.3%) | -$92.75 M(-10.0%) |
| Dec 2019 | -$103.08 M(+42.2%) | -$25.47 M(-8.1%) | -$103.08 M(+5.0%) |
| Sept 2019 | - | -$27.71 M(+8.0%) | -$98.16 M(+7.2%) |
| June 2019 | - | -$25.65 M(+5.8%) | -$91.58 M(+9.1%) |
| Mar 2019 | - | -$24.25 M(+18.0%) | -$83.91 M(+15.7%) |
| Dec 2018 | -$72.50 M | -$20.55 M(-2.7%) | -$72.50 M(+28.8%) |
| Sept 2018 | - | -$21.13 M(+17.6%) | -$56.31 M(+35.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$17.97 M(+39.9%) | -$41.57 M(+33.1%) |
| Mar 2018 | - | -$12.85 M(+195.0%) | -$31.23 M(+46.4%) |
| Dec 2017 | -$21.32 M(-16.7%) | -$4.36 M(-31.9%) | -$21.32 M(-9.9%) |
| Sept 2017 | - | -$6.39 M(-16.2%) | -$23.66 M(+3.2%) |
| June 2017 | - | -$7.63 M(+158.6%) | -$22.93 M(+5.9%) |
| Mar 2017 | - | -$2.95 M(-55.9%) | -$21.65 M(-15.4%) |
| Dec 2016 | -$25.59 M(-1.2%) | -$6.69 M(+18.1%) | -$25.59 M(+3.4%) |
| Sept 2016 | - | -$5.66 M(-10.7%) | -$24.75 M(-4.1%) |
| June 2016 | - | -$6.35 M(-7.9%) | -$25.81 M(-0.8%) |
| Mar 2016 | - | -$6.89 M(+17.8%) | -$26.01 M(+0.4%) |
| Dec 2015 | -$25.90 M(+7.9%) | -$5.85 M(-13.1%) | -$25.90 M(-6.4%) |
| Sept 2015 | - | -$6.73 M(+2.8%) | -$27.66 M(+4.5%) |
| June 2015 | - | -$6.54 M(-3.4%) | -$26.46 M(+3.1%) |
| Mar 2015 | - | -$6.78 M(-10.9%) | -$25.67 M(+6.9%) |
| Dec 2014 | -$24.01 M(+155.5%) | -$7.61 M(+37.5%) | -$24.01 M(+20.9%) |
| Sept 2014 | - | -$5.54 M(-3.7%) | -$19.85 M(+26.4%) |
| June 2014 | - | -$5.75 M(+12.4%) | -$15.70 M(+29.8%) |
| Mar 2014 | - | -$5.12 M(+48.1%) | -$12.10 M(+28.7%) |
| Dec 2013 | -$9.40 M(-10.0%) | -$3.45 M(+149.2%) | -$9.40 M(+58.1%) |
| Sept 2013 | - | -$1.39 M(-35.3%) | -$5.94 M(+30.4%) |
| June 2013 | - | -$2.14 M(-11.3%) | -$4.56 M(+88.7%) |
| Mar 2013 | - | -$2.42 M | -$2.42 M |
| Dec 2012 | -$10.44 M | - | - |
FAQ
- What is CymaBay Therapeutics annual operaing income?
- What is the all time high annual operating profit for CymaBay Therapeutics?
- What is CymaBay Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for CymaBay Therapeutics?
- What is CymaBay Therapeutics TTM operating income?
- What is the all time high TTM operating profit for CymaBay Therapeutics?
What is CymaBay Therapeutics annual operaing income?
The current annual operating profit of CBAY is -$101.68 M
What is the all time high annual operating profit for CymaBay Therapeutics?
CymaBay Therapeutics all-time high annual operaing income is -$9.40 M
What is CymaBay Therapeutics quarterly operating income?
The current quarterly operating profit of CBAY is -$42.50 M
What is the all time high quarterly operating profit for CymaBay Therapeutics?
CymaBay Therapeutics all-time high quarterly operating income is -$99.00 K
What is CymaBay Therapeutics TTM operating income?
The current TTM operating profit of CBAY is -$101.68 M
What is the all time high TTM operating profit for CymaBay Therapeutics?
CymaBay Therapeutics all-time high TTM operating income is -$2.42 M